hotspot -WSS

hotspot

author：entertainment 2025-10-01 02:15:15 - browse：19732

UCB website -- health policy coverage from STAT — Adobe

WASHINGTON — UCB left BIO at the end of 2023, the second major member company to exit after Pfizer pulled out as well.

UCB, headquartered in Belgium, decided not to renew its BIO membership after a routine evaluation of its engagement in trade associations, said company spokesperson Erica Puntel.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

Pfizer, whose departure STAT reported first, was listed on BIO’s website as a sponsor at one of the group’s highest levels. Pfizer bought Global Blood Therapeutics, which current BIO Board Chair Ted Love led to the approval of a drug to treat sickle cell disease, in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Aspartame and sugar

focus

WSS

Congress extends some pandemic preparedness programs

6 solutions to address cancer drug shortages and others

Health AI: on the border between health care and tech

Flu, Covid vaccination rates decline, new survey data show

Flu, Covid vaccination rates decline, new survey data show

6 solutions to address cancer drug shortages and others

hotspot

hotspot

Sign up for D.C. Diagnosis

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

6 solutions to address cancer drug shortages and others

State Dept. review finds Biden bears some blame for Afghanistan failures

Some top drug companies are starting to take action on climate

Hollywood unions extend contract negotiations for actors

The Karikó problem: Lessons for funding basic research

Drug repurposing or repositioning? The language matters

CDC picks Alphabet's Verily for wasterwater surveillance contract

Novavax promises a turnaround & Lilly roils the obesity market

The biotech scorecard for Q4: 16 stock

explore

What to know about the judge who will handle the Trump case

What will Novo Nordisk's VC do with its influx of cash?

Senators push IRS to launch nonprofit hospital probe

Montana youths win climate lawsuit against state for promoting fossil fuels

Experts study whether long Covid risk adds up with each reinfection

Illumina slashes 2023 revenue projections yet again

Wikipedia

knowledge

focus

Wikipedia